Abstract
The burden of prostate cancer is increasing. Therefore, we need to implement a contemporary, organized, risk-stratified program for early detection to reduce both the harm from the disease and potential overdiagnosis and overtreatment, while avoiding underdiagnosis to considerably improve the harm-to-benefit ratio.
Original language | English |
---|---|
Pages (from-to) | 327-329 |
Number of pages | 3 |
Journal | European Urology |
Volume | 79 |
Issue number | 3 |
DOIs | |
Publication status | Published - Mar 2021 |
Research programs
- EMC OR-01